Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone enanthate for anemia and quality of life in patients with end-stage renal disease on hemodialysis
ACTRN12624001137583Phase 4Completed
- Sponsor
- Pak Emirates Military Hospital
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of testosterone enanthate in anaemia and end-stage kidney disease (ESKD), sponsored by Pak Emirates Military Hospital. Started Jan 2024; status: completed.
02
Drugs
testosterone enanthate
03
Conditions
anaemiaend-stage kidney disease (ESKD)
Beyond the preview
Go deeper on ACTRN12624001137583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12624001137583.